Amazon Pharmacy is rolling out coupons that “automatically” reduce customer costs for insulin to as low as $35 a month on more than a dozen diabetes care brands.
The market’s obsession with data science and artificial intelligence is reflected in this year’s list of 25 companies we think most likely to reach $1 billion valuation.
Biotech researcher Colleen Cutcliffe designed probiotics to help diabetics lower their blood sugar. Now she’s got a handful of expensive supplements for sale — and Halle Berry on board to help sell them.
There are more than 50,000 venture-backed startups in the U.S., and only the tiniest fraction will ever reach a $1 billion valuation. Here are the 25 we think most likely to succeed.